Department of Opthalmology, Vardinoyannion Eye Institute of Crete, Crete, Greece.
J Refract Surg. 2013 Jan;29(1):12-8. doi: 10.3928/1081597X-20121210-01.
To evaluate the outcomes and safety of a refractive inlay (Flexivue Micro-Lens, Presbia Coöperatief U.A.) for the corneal compensation of presbyopia.
This prospective, interventional clinical study comprised 47 emmetropic presbyopes with a mean age of 52±4 years (range: 45 to 60 years). The inlay was inserted, centered on the line of sight, inside a corneal pocket created in the patient's nondominant eye, using a femtosecond laser. Follow-up was 12 months. Visual acuity, corneal topography, wavefront aberrometry, contrast sensitivity, structural corneal alterations, and questionnaires were evaluated.
Twelve months after surgery, uncorrected near visual acuity was 20/32 or better in 75% of operated eyes, whereas mean uncorrected distance visual acuity (UDVA) of operated eyes was statistically significantly decreased from 0.06±0.09 logMAR (20/20) (range: -0.08 to 0.26) preoperatively to 0.38±0.15 logMAR (20/50) (range: 0.12 to 0.8) (P<.001), and mean binocular UDVA was not significantly altered (P=.516). Seventeen patients lost one line of corrected distance visual acuity in the operated eye. No patient lost 2 lines in CDVA in the operated eye. Overall, higher order aberrations increased and contrast sensitivity decreased in the operated eye. No tissue alterations were found using corneal confocal microscopy. No intra- or postoperative complications occurred.
Twelve months after implantation, the Flexivue Micro-Lens intracorneal refractive inlay seems to be an effective method for the corneal compensation of presbyopia in emmetropic presbyopes aged between 45 and 60 years old.
评估用于矫正远视的折射嵌体(Flexivue Micro-Lens,Presbia Coöperatief U.A.)的疗效和安全性。
本前瞻性、干预性临床研究纳入了 47 名平均年龄为 52±4 岁(45 至 60 岁)的正视远视患者。使用飞秒激光在患者非主导眼的角膜内创建一个口袋,将嵌体置于口袋中央的视线处。随访时间为 12 个月。评估视力、角膜地形图、波前像差、对比敏感度、结构角膜改变和问卷调查。
术后 12 个月,75%的手术眼未矫正近视力达到 20/32 或更好,而手术眼平均未矫正远视力(UDVA)从术前的 0.06±0.09 logMAR(20/20)(范围:-0.08 至 0.26)显著下降至 0.38±0.15 logMAR(20/50)(范围:0.12 至 0.8)(P<.001),双眼 UDVA 无显著变化(P=.516)。17 名患者手术眼的远视力矫正值下降了一行。没有患者手术眼的远视力矫正值下降了两行。总体而言,高阶像差增加,手术眼的对比敏感度下降。角膜共聚焦显微镜未发现组织改变。未发生术中或术后并发症。
植入后 12 个月,Flexivue Micro-Lens 角膜内折射嵌体似乎是一种治疗 45 至 60 岁正视远视患者远视的有效方法。